2.81 USD
-0.02 (-0.71%)
2.85 USD
+0.04 (+1.42%)
Overall GDRX gets a fundamental rating of 6 out of 10. We evaluated GDRX against 35 industry peers in the Health Care Technology industry. Both the profitability and the financial health of GDRX get a neutral evaluation. Nothing too spectacular is happening here. GDRX scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings could make GDRX a good candidate for value investing.
1. Profitability
1.1 Basic Checks
In the past year GDRX was profitable.
GDRX had a positive operating cash flow in the past year.
In the past 5 years GDRX reported 4 times negative net income.
GDRX had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
GDRX's Return On Assets of 2.40% is amongst the best of the industry. GDRX outperforms 85.71% of its industry peers.
Looking at the Return On Equity, with a value of 5.29%, GDRX belongs to the top of the industry, outperforming 91.43% of the companies in the same industry.
The Return On Invested Capital of GDRX (5.73%) is better than 88.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.4% | ||
| ROE | 5.29% | ||
| ROIC | 5.73% |
ROA(3y)-0.47%
ROA(5y)-4.59%
ROE(3y)-0.98%
ROE(5y)-9.45%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
GDRX has a Profit Margin of 3.97%. This is amongst the best in the industry. GDRX outperforms 88.57% of its industry peers.
In the last couple of years the Profit Margin of GDRX has declined.
With an excellent Operating Margin value of 10.37%, GDRX belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
In the last couple of years the Operating Margin of GDRX has declined.
The Gross Margin of GDRX (93.46%) is better than 100.00% of its industry peers.
GDRX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.37% | ||
| PM (TTM) | 3.97% | ||
| GM | 93.46% |
OM growth 3Y66.59%
OM growth 5Y-25.41%
PM growth 3YN/A
PM growth 5Y-34.38%
GM growth 3Y0.06%
GM growth 5Y-0.52%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GDRX is destroying value.
GDRX has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, GDRX has about the same amount of shares outstanding.
GDRX has a better debt/assets ratio than last year.
2.2 Solvency
GDRX has an Altman-Z score of 0.45. This is a bad value and indicates that GDRX is not financially healthy and even has some risk of bankruptcy.
GDRX's Altman-Z score of 0.45 is in line compared to the rest of the industry. GDRX outperforms 54.29% of its industry peers.
GDRX has a debt to FCF ratio of 4.66. This is a neutral value as GDRX would need 4.66 years to pay back of all of its debts.
With a Debt to FCF ratio value of 4.66, GDRX perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
A Debt/Equity ratio of 0.81 indicates that GDRX is somewhat dependend on debt financing.
GDRX has a Debt to Equity ratio of 0.81. This is in the lower half of the industry: GDRX underperforms 74.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.81 | ||
| Debt/FCF | 4.66 | ||
| Altman-Z | 0.45 |
ROIC/WACC0.52
WACC11.01%
2.3 Liquidity
A Current Ratio of 3.11 indicates that GDRX has no problem at all paying its short term obligations.
GDRX has a better Current ratio (3.11) than 65.71% of its industry peers.
GDRX has a Quick Ratio of 3.11. This indicates that GDRX is financially healthy and has no problem in meeting its short term obligations.
GDRX has a Quick ratio of 3.11. This is in the better half of the industry: GDRX outperforms 71.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.11 | ||
| Quick Ratio | 3.11 |
3. Growth
3.1 Past
GDRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.37%, which is quite good.
GDRX shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -24.47% yearly.
The Revenue has been growing slightly by 1.30% in the past year.
GDRX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.34% yearly.
EPS 1Y (TTM)9.37%
EPS 3Y0%
EPS 5Y-24.47%
EPS Q2Q%0%
Revenue 1Y (TTM)1.3%
Revenue growth 3Y2.06%
Revenue growth 5Y15.34%
Sales Q2Q%0.4%
3.2 Future
GDRX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.32% yearly.
GDRX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.00% yearly.
EPS Next Y15.26%
EPS Next 2Y18.79%
EPS Next 3Y17.59%
EPS Next 5Y25.32%
Revenue Next Year0.55%
Revenue Next 2Y2.9%
Revenue Next 3Y4.52%
Revenue Next 5Y5%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
GDRX is valuated reasonably with a Price/Earnings ratio of 8.03.
Based on the Price/Earnings ratio, GDRX is valued cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of GDRX to the average of the S&P500 Index (26.31), we can say GDRX is valued rather cheaply.
GDRX is valuated cheaply with a Price/Forward Earnings ratio of 6.03.
Based on the Price/Forward Earnings ratio, GDRX is valued cheaper than 100.00% of the companies in the same industry.
GDRX is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.59, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.03 | ||
| Fwd PE | 6.03 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, GDRX is valued cheaper than 94.29% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, GDRX is valued cheaper than 94.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.09 | ||
| EV/EBITDA | 7.12 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
GDRX has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as GDRX's earnings are expected to grow with 17.59% in the coming years.
PEG (NY)0.53
PEG (5Y)N/A
EPS Next 2Y18.79%
EPS Next 3Y17.59%
5. Dividend
5.1 Amount
GDRX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
2.81
-0.02 (-0.71%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners58.63%
Inst Owner Change-2.53%
Ins Owners11.85%
Ins Owner Change9.33%
Market Cap953.80M
Revenue(TTM)800.65M
Net Income(TTM)31.75M
Analysts76.19
Price Target5.22 (85.77%)
Short Float %9.25%
Short Ratio1.82
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-12.02%
Min EPS beat(2)-13.38%
Max EPS beat(2)-10.65%
EPS beat(4)0
Avg EPS beat(4)-9.95%
Min EPS beat(4)-13.38%
Max EPS beat(4)-7.12%
EPS beat(8)2
Avg EPS beat(8)-4.79%
EPS beat(12)6
Avg EPS beat(12)4.06%
EPS beat(16)9
Avg EPS beat(16)11.21%
Revenue beat(2)0
Avg Revenue beat(2)-2.26%
Min Revenue beat(2)-3.3%
Max Revenue beat(2)-1.22%
Revenue beat(4)0
Avg Revenue beat(4)-2.17%
Min Revenue beat(4)-3.3%
Max Revenue beat(4)-1.22%
Revenue beat(8)0
Avg Revenue beat(8)-1.92%
Revenue beat(12)1
Avg Revenue beat(12)-1.83%
Revenue beat(16)2
Avg Revenue beat(16)-1.59%
PT rev (1m)-3.78%
PT rev (3m)-3.78%
EPS NQ rev (1m)-4.77%
EPS NQ rev (3m)-4.77%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.41%
Revenue NQ rev (1m)-2.53%
Revenue NQ rev (3m)-2.69%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.1%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.03 | ||
| Fwd PE | 6.03 | ||
| P/S | 1.19 | ||
| P/FCF | 9.09 | ||
| P/OCF | 5.31 | ||
| P/B | 1.59 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.12 |
EPS(TTM)0.35
EY12.46%
EPS(NY)0.47
Fwd EY16.57%
FCF(TTM)0.31
FCFY11%
OCF(TTM)0.53
OCFY18.85%
SpS2.36
BVpS1.77
TBVpS-0.08
PEG (NY)0.53
PEG (5Y)N/A
Graham Number3.73
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.4% | ||
| ROE | 5.29% | ||
| ROCE | 7.26% | ||
| ROIC | 5.73% | ||
| ROICexc | 7.53% | ||
| ROICexgc | 26.92% | ||
| OM | 10.37% | ||
| PM (TTM) | 3.97% | ||
| GM | 93.46% | ||
| FCFM | 13.11% |
ROA(3y)-0.47%
ROA(5y)-4.59%
ROE(3y)-0.98%
ROE(5y)-9.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y37.95%
ROICexgc growth 5Y-33.14%
ROICexc growth 3Y52.2%
ROICexc growth 5Y-28.33%
OM growth 3Y66.59%
OM growth 5Y-25.41%
PM growth 3YN/A
PM growth 5Y-34.38%
GM growth 3Y0.06%
GM growth 5Y-0.52%
F-Score6
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.81 | ||
| Debt/FCF | 4.66 | ||
| Debt/EBITDA | 2.95 | ||
| Cap/Depr | 92.2% | ||
| Cap/Sales | 9.35% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 109.5% | ||
| Profit Quality | 330.43% | ||
| Current Ratio | 3.11 | ||
| Quick Ratio | 3.11 | ||
| Altman-Z | 0.45 |
F-Score6
WACC11.01%
ROIC/WACC0.52
Cap/Depr(3y)84.93%
Cap/Depr(5y)109.87%
Cap/Sales(3y)7.84%
Cap/Sales(5y)6.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.37%
EPS 3Y0%
EPS 5Y-24.47%
EPS Q2Q%0%
EPS Next Y15.26%
EPS Next 2Y18.79%
EPS Next 3Y17.59%
EPS Next 5Y25.32%
Revenue 1Y (TTM)1.3%
Revenue growth 3Y2.06%
Revenue growth 5Y15.34%
Sales Q2Q%0.4%
Revenue Next Year0.55%
Revenue Next 2Y2.9%
Revenue Next 3Y4.52%
Revenue Next 5Y5%
EBIT growth 1Y179.68%
EBIT growth 3Y70.01%
EBIT growth 5Y-13.97%
EBIT Next Year32.27%
EBIT Next 3Y16.67%
EBIT Next 5Y13.87%
FCF growth 1Y9.18%
FCF growth 3Y-7.68%
FCF growth 5Y7.91%
OCF growth 1Y16.5%
OCF growth 3Y0.94%
OCF growth 5Y17.16%
GOODRX HOLDINGS INC-CLASS A / GDRX FAQ
Can you provide the ChartMill fundamental rating for GOODRX HOLDINGS INC-CLASS A?
ChartMill assigns a fundamental rating of 6 / 10 to GDRX.
Can you provide the valuation status for GOODRX HOLDINGS INC-CLASS A?
ChartMill assigns a valuation rating of 9 / 10 to GOODRX HOLDINGS INC-CLASS A (GDRX). This can be considered as Undervalued.
What is the profitability of GDRX stock?
GOODRX HOLDINGS INC-CLASS A (GDRX) has a profitability rating of 6 / 10.
What is the valuation of GOODRX HOLDINGS INC-CLASS A based on its PE and PB ratios?
The Price/Earnings (PE) ratio for GOODRX HOLDINGS INC-CLASS A (GDRX) is 8.03 and the Price/Book (PB) ratio is 1.59.
Can you provide the financial health for GDRX stock?
The financial health rating of GOODRX HOLDINGS INC-CLASS A (GDRX) is 5 / 10.